In vitro activity of a novel des-fluoro(6) quinolone, garenoxacin (BMS-284756), against rapidly growing mycobacteria and Nocardia isolates

被引：8
|
作者：
Valera, L [1 ]
Gradelski, E [1 ]
Huczko, E [1 ]
Washo, T [1 ]
Yigit, H [1 ]
Fung-Tomc, J [1 ]
机构：
[1] Bristol Myers Squibb Co, Dept Microbiol, Wallingford, CT 06492 USA
来源：
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 2002年 / 50卷 / 01期
关键词：
D O I：
10.1093/jac/dkf081
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：140A / 142
页数：3
相关论文
共 48 条
  • [1] Antibacterial spectrum of a novel des-fluoro(6) quinolone, BMS-284756
    Fung-Tomc, JC
    Minassian, B
    Kolek, B
    Huczko, E
    Aleksunes, L
    Stickle, T
    Washo, T
    Gradelski, E
    Valera, L
    Bonner, DP
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (12) : 3351 - 3356
  • [2] Intracellular penetration and bactericidal activity of the novel des-fluoro(6) quinolone, BMS-284756
    Kolek, B
    Warr, G
    Bonner, D
    Tomc, JF
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2001, 48 (03) : 445 - 446
  • [3] Antimicrobial activity of a novel des-fluoro (6) quinolone, garenoxacin (BMS-284756), compared to other quinolones, against clinical isolates from cancer patients
    Rolston, KVI
    Frisbee-Hume, S
    LeBlanc, BM
    Streeter, H
    Ho, DH
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2002, 44 (02) : 187 - 194
  • [4] Increased in vitro activity of the novel des-fluoro(6) quinolone BMS-284756 against genetically defined clinical isolates of Staphylococcus aureus
    Schmitz, FJ
    Boos, M
    Mayer, S
    Jagusch, H
    Fluit, AC
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2002, 49 (02) : 283 - 287
  • [5] Activity of the novel des-fluoro(6) quinolone BMS-284756 against methicillin-susceptible and -resistant staphylococci
    Fung-Tomc, J
    Valera, L
    Minassian, B
    Bonner, D
    Gradelski, E
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2001, 48 (05) : 735 - 738
  • [6] Activity of BMS-284756, a novel des-fluoro(6) quinolone, against Staphylococcus aureus, including contributions of mutations to quinolone resistance
    Low, DE
    Muller, M
    Duncan, CL
    Willey, BM
    de Azavedo, JC
    McGeer, A
    Kreiswirth, BN
    Pong-Porter, S
    Bast, DJ
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (04) : 1119 - 1121
  • [7] Synergistic activity of the novel des-fluoro(6) quinolone, garenoxacin (BMS-284756), in combination with other antimicrobial agents against Pseudomonas aeruginosa and related species
    Fung-Tomc, JC
    Gradelski, E
    Valera, L
    Huczko, E
    Bonner, DP
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2002, 20 (01) : 57 - 60
  • [8] Activity of the investigational des-fluoro(6)-quinolone BMS-284756 against multi-drug-resistant isolates of Streptococcus pneumoniae
    Jorgensen, JH
    Crawford, SA
    Mcelmeel, ML
    Whitney, CG
    CLINICAL INFECTIOUS DISEASES, 2001, 33 (07) : 1166 - 1166
  • [9] Comparative killing kinetics of the novel des-fluoro(6) quinolone BMS-284756, fluoroquinolones, vancomycin and β-lactams
    Gradelski, E
    Valera, L
    Kolek, B
    Bonner, D
    Fung-Tomc, J
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2001, 18 (01) : 43 - 48
  • [10] Activity of BMS-284756, a novel DES-fluoro(6)quinolone, in combination with selected antimicrobials against multi-drug resistant organisms
    Dawis, MA
    France, KA
    Isenberg, HD
    Jenkins, SG
    CLINICAL INFECTIOUS DISEASES, 2001, 33 (07) : 1166 - 1166
12345